Literature DB >> 28869105

Correlation between HBV protein preS2 and tumor markers of hepatocellular carcinoma.

Fang Luan1, Bin Liu2, Junguo Zhang1, Shiqing Cheng1, Bingchang Zhang1, Yong Wang3.   

Abstract

BACKGROUND: Alpha-fetoprotein (AFP) and Glypican 3 (GPC3) are both oncogenes and reactivated in hepatocellular carcinoma (HCC). PreS2 has been proved to be an important transactivator in HCC. In this study, we aim to provide evidence that HBV protein preS2 is responsible for AFP and GPC3's reactivation in HCC.
METHODS: Totally Sixty-three cases of HCC, aged 34-79, who were surgically treated and pathologically confirmed were enrolled. The levels of AFP in peripheral serum were detected with electrochemical luminescence method before surgery. Levels of GPC3 in HCC samples were evaluated by immunohistochemistry. Luciferase reporter assays were used to measure the effect of preS2 on AFP and GPC3 promoters.
RESULTS: AFP level and GPC3 but not albumin were significantly higher in preS2-positive HCC samples than preS2-negative HCC samples. And the preS2 protein expression was positively related with serum AFP level and GPC3 expression. Furtherly, dual luciferase assay showed that preS2 activated AFP and GPC3 promoter activity.
CONCLUSION: The expression of preS2 protein relates closely to HCC markers AFP and GPC3.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Alpha-fetoprotein; Glypican3; HBV protein preS2; Hepatocellular carcinoma

Mesh:

Substances:

Year:  2017        PMID: 28869105     DOI: 10.1016/j.prp.2017.08.007

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  2 in total

1.  Enigmatic PreS deletions in hepatitis B virus DNA.

Authors:  Wolfram H Gerlich; Dieter Glebe
Journal:  Virus Genes       Date:  2020-11-05       Impact factor: 2.332

Review 2.  Pathogenicity and virulence of Hepatitis B virus.

Authors:  Yu-Chen Chuang; Kuen-Nan Tsai; Jing-Hsiung James Ou
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.